Author:
Yoon Stephanie M.,Deng Jie,Wong Kirsten,Lee Alan,Venkat Puja,Chang Albert J.
Publisher
Springer International Publishing
Reference62 articles.
1. Howlander N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER cancer statistics review. https://seer.cancer.gov/csr/1975_2017/. Accessed 2020.
2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–94.
3. Mohammed TL, Chowdhry A, Reddy GP, et al. ACR Appropriateness Criteria® screening for pulmonary metastases. J Thorac Imaging. 2011;26(1):W1–3.
4. Skowronek J. Brachytherapy in the treatment of lung cancer—a valuable solution. J Contemp Brachytherapy. 2015;7(4):297–311.
5. Gomez DR, Blumenschein GR Jr, Lee JJ, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016;17(12):1672–82.